Osmotica Pharmaceutical US LLC et al v. Adamas Pharmaceuticals, Inc. et al
| Osmotica Pharmaceutical US LLC and Vertical Pharmaceuticals, LLC |
| Adamas Pharma, LLC and Adamas Pharmaceuticals, Inc. |
| 1:2018cv00278 |
| February 16, 2018 |
| U.S. District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Colm F Connolly |
| Gregory M Sleet |
| Patent |
| 35 U.S.C. § 271 |
| Plaintiff |
Docket Report
This docket was last retrieved on December 30, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 116 REDACTED VERSION of #115 Letter (Joint) re Status of Case by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 115 [SEALED] Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 114 REDACTED VERSION of #113 Letter (Joint) re Status of Case by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 113 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 112 REDACTED VERSION of #111 Letter (Joint) re Status of Case by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 111 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 110 REDACTED VERSION of #109 Letter (Joint) re Status of Case by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 109 [SEALED] Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding [Joint Status Update]. (Poff, Adam) |
| Filing 108 REDACTED VERSION of #107 Letter regarding case status by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 107 [SEALED] Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 106 REDACTED VERSION of #105 Letter re Joint Status Report by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 105 [SEALED] Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 104 REDACTED VERSION of #103 Letter by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 103 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 102 REDACTED VERSION of #101 Letter regarding case status by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 101 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 100 REDACTED VERSION of #99 Letter - Joint Status Report by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 99 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 98 REDACTED VERSION of #97 Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 97 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 96 REDACTED VERSION of #95 Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 95 [SEALED] Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 94 REDACTED VERSION of #91 Letter by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 93 REDACTED VERSION of #90 Letter by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 92 REDACTED VERSION of #89 Letter by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 91 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 90 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| Filing 89 [SEALED] Joint Letter to The Honorable Colm F. Connolly from Adam W. Poff regarding status of case - re #88 Order Staying Case. (Poff, Adam) |
| The 6/17/2019 Markman Hearing is cancelled as the case is stayed. (nmf) |
| Filing 88 [SEALED] STIPULATION to Stay. Signed by Judge Colm F. Connolly on 5/23/2019.This order has been emailed to local counsel. (fms) |
| Filing 87 [SEALED] STIPULATION to Stay Litigation by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| CORRECTING ENTRY: Per request of counsel, the stipulation filed on 5/21/2019 at D.I. 87 has been removed and will be refiled shortly. (fms) |
| Filing 86 STIPULATION TO EXTEND TIME to file Joint Claim Construction Brief to May 20, 2019 - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
SO ORDERED, re #86 STIPULATION TO EXTEND TIME to file Joint Claim Construction Brief to May 20, 2019 filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Signed by Judge Colm F. Connolly on 5/17/2019. (nmf)
|
| Filing 85 NOTICE OF SERVICE of Adamas' Sur-Reply Claim Construction Brief filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 84 REQUEST for Oral Argument by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC re #73 MOTION for Leave to File a Second Amended Answer and Counterclaims. (Kraman, Pilar) |
| Filing 83 NOTICE OF SERVICE of Adamas' Supplemental Responses and Objections to Plaintiffs' Interrogatory Nos. 1-4 filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
ORAL ORDER Rescheduling Hearings: The Markman Hearing is rescheduled to begin at 9:00 AM on 6/17/2019 in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 5/15/2019. (nmf)
|
| CORRECTING ENTRY: The pdf at D.I. #82 has been replaced with the pdf of the Notice of Service instead of the document itself which had been filed originally. (nmf) |
| Filing 82 NOTICE OF SERVICE of Adamas' Third Set of Request for the Production of Documents and Things filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) (Main Document 82 replaced on 5/2/2019) (nmf, ). |
| Filing 81 NOTICE OF SERVICE of 1) Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 117-136) to Defendants Adamas Pharmaceuticals, Inc. and Adamas Pharma, LLC; and 2) Plaintiffs Third Set of Interrogatories to Defendants (No. 8) filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 80 REPLY BRIEF re #73 MOTION for Leave to File a Second Amended Answer and Counterclaims filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Attachments: #1 Exhibits 18-24)(Lyons, Jeffrey) |
| Filing 79 ANSWERING BRIEF in Opposition re #73 MOTION for Leave to File a Second Amended Answer and Counterclaims filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.Reply Brief due date per Local Rules is 4/22/2019. (Attachments: #1 Exhibit 11 through 17)(Kraman, Pilar) |
| Filing 78 REDACTED VERSION of #74 Opening Brief in Support, of Motion for Leave to File a Second Amended Answer and Counterclaims by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Attachments: #1 Exhibit 1-10)(Lyons, Jeffrey) |
| CORRECTING ENTRY: The pdf of Exhibit A to D.I. #73 has been replaced per request of filer with a corrected version to correct the name of one of the parties in the caption. (nmf) |
| Filing 77 NOTICE OF SERVICE of Adamas' Answering Claim Construction Brief filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
SO ORDERED, re #76 STIPULATION TO EXTEND TIME for Plaintiffs to File Answering Brief and Defendants to File Reply Brief regarding Defendants' Motion for Leave to File a Second Amended Answer and Counterclaims to April 15, 2019 and April 25, 2019, respectively filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Set Briefing Schedule: re #73 MOTION for Leave to File a Second Amended Answer and Counterclaims. (Answering Brief due 4/15/2019., Reply Brief due 4/25/2019.). Signed by Judge Colm F. Connolly on 3/29/2019. (fms)
|
| Filing 76 STIPULATION TO EXTEND TIME for Plaintiffs to File Answering Brief and Defendants to File Reply Brief regarding Defendants' Motion for Leave to File a Second Amended Answer and Counterclaims to April 15, 2019 and April 25, 2019, respectively - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Kraman, Pilar) |
| Pro Hac Vice Attorney Matthew M. Zuziak for Osmotica Pharmaceutical US LLC and Vertical Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg) |
| Filing 75 MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Zuziak - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Kraman, Pilar) |
SO ORDERED, re #75 MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Zuziak filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Signed by Judge Colm F. Connolly on 3/22/2019. (fms)
|
| Filing 74 [SEALED] OPENING BRIEF in Support re #73 MOTION for Leave to File a Second Amended Answer and Counterclaims filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 4/3/2019. (Attachments: #1 Exhibit 1-10)(Tigan, Jeremy) |
| Filing 73 MOTION for Leave to File a Second Amended Answer and Counterclaims - filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit A-I to Second Amended Answer, #3 Exhibit B)(Tigan, Jeremy) |
| Filing 72 NOTICE OF SERVICE of Adamas' Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 6-7) filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Blumenfeld, Jack) |
| Filing 71 NOTICE OF SERVICE of Plaintiffs Responses & Objections to Defendants Second Set of Requests for the Production of Documents and Things (Nos. 27-51) filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Poff, Adam) |
| Filing 70 NOTICE requesting Clerk to remove Daniel J. Ritterbeck as co-counsel. Reason for request: no longer with Sterne, Kessler, Goldstein & Fox P.L.L.C.. (Kraman, Pilar) |
| Filing 69 NOTICE OF SERVICE of 1) Plaintiffs Opening Claim Construction Brief and Exhibits and 2) Declaration of Richard Bergstrom Concerning Indefiniteness filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 68 NOTICE OF SERVICE of Adamas' Second Amended Initial Disclosures Regarding Custodians and Non-Custodial Data Sources filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 67 CLAIM Construction Chart by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Attachments: #1 Exhibit A through N)(Poff, Adam) |
| Filing 66 NOTICE OF SERVICE of Plaintiffs Second Set of Interrogatories to Defendants (Nos. 6-7) filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
SO ORDERED, re #65 Joint STIPULATION TO EXTEND TIME to submit a Joint Claim Construction Chart to February 5, 2019 filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/1/2019. (fms)
|
| Filing 65 Joint STIPULATION TO EXTEND TIME to submit a Joint Claim Construction Chart to February 5, 2019 - filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Filing 64 NOTICE OF SERVICE of Adamas' Second Set of Requests for the Production of Documents and Things filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 63 NOTICE OF SERVICE of Adamas' Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-5) filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 62 NOTICE OF SERVICE of (1) Adamas' First Amended Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1); and (2) Adamas' First Amended Initial Disclosures Regarding Custodians and Non-Custodial Data Sources filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 61 NOTICE OF SERVICE of Plaintiffs Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 60 Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Requesting Oral Argument on Osmotica's Motion to Dismiss Adamas' 35 U.S.C. 271(e)(2) Claims Under Fed. R. Civ. P. 12(b)(6) and 12(b)(1) - re #35 MOTION to Dismiss Based upon Fed. R. Civ. P. 12(b)(6) and 12(b)(1) Adamas' 35 U.S.C. 271(e)(2) Claims. (Tigan, Jeremy) |
| Filing 59 NOTICE OF SERVICE of Adamas' Identification of Evidence to Oppose Plaintiffs' Proposed Constructions and Intrinsic Evidence in Support of Defendants' Proposed Constructions Thereof filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 58 NOTICE OF SERVICE of Plaintiffs Proposed Claim Constructions and Evidence Opposing Adamas Construction filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Pro Hac Vice Attorney Dennies Varughese for Osmotica Pharmaceutical US LLC and Vertical Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Filing 57 REPLY BRIEF re #35 MOTION to Dismiss Based upon Fed. R. Civ. P. 12(b)(6) and 12(b)(1) Adamas' 35 U.S.C. 271(e)(2) Claims filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Attachments: #1 Exhibit A through G)(Poff, Adam) |
| Filing 56 NOTICE of Subpoena Duces Tecum to Orbit Co-Invest A-1 LLC by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. (Attachments: #1 Exhibit 1)(Tigan, Jeremy) |
| Filing 55 NOTICE of Subpoena Duces Tecum to Avista Capital Holdings, L.P. by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. (Attachments: #1 Exhibit 1)(Tigan, Jeremy) |
| Filing 54 NOTICE of Subpoena Duces Tecum to Vertical/Trigen Holdings, LLC by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. (Attachments: #1 Exhibit 1)(Tigan, Jeremy) |
| Filing 53 NOTICE of Subpoena Duces Tecum to Osmotica Pharmaceutical Corp. by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. (Attachments: #1 Exhibit 1)(Tigan, Jeremy) |
| Filing 52 NOTICE of Subpoena Duces Tecum to Osmotica Holdings US LLC by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. (Attachments: #1 Exhibit 1)(Tigan, Jeremy) |
| Filing 51 NOTICE OF SERVICE of 1) Plaintiffs Proposed Claim Constructions and Supporting Evidence; and 2) Plaintiffs First Supplemental Responses and Objections to Defendants First Set of Interrogatories filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Poff, Adam) |
| Filing 50 NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants (Nos. 1-5) filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 49 NOTICE OF SERVICE of Adamas' Preliminary Claim Constructions nd Intrinsic Evidence in Support Thereof filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| CORRECTING ENTRY: Per request of filer, Exhibits A-D attached to D.I. #48 have been removed and replaced with a version that removes highlighting in Exhibit B. (fms) |
| Filing 48 ANSWERING BRIEF in Opposition re #35 MOTION to Dismiss Based upon Fed. R. Civ. P. 12(b)(6) and 12(b)(1) Adamas' 35 U.S.C. 271(e)(2) Claims filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/26/2018. (Attachments: #1 Exhibits A-D)(Tigan, Jeremy) (Attachment 1 replaced on 12/20/2018) (fms). |
Filing 47
ORDER Setting Mediation Conference: A Telephone Conference is set for 1/28/2019 at 10:15 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 12/17/2018. (dlb)
|
Filing 46
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/20/2019. Amended Pleadings due by 3/20/2019. Fact Discovery completed by 8/19/2019. Dispositive Motions due by 1/17/2020. Joint Claim Construction Brief due by 5/17/2019. A Markman Hearing is set for 6/17/2019 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 5/13/2020 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 6/1/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/10/2018. (nmf)
|
| Filing 45 PROPOSED ORDER Scheduling Order by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Filing 44 NOTICE OF SERVICE of Adamas' Proposed Terms for Construction filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Blumenfeld, Jack) |
| Filing 43 NOTICE OF SERVICE of Plaintiffs' List of Claim Terms for Construction filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
Filing 42
ORDER, IT IS ORDERED that, on or before December 5, 2018, the Plaintiffs shall submit a proposed revised scheduling order that incorporates the dates and discovery limitations currently in effect and comports with the Court's "Rule 16 Scheduling Order for Patent Cases"(revised on November 14, 2018) except that the Pretrial Conference shall be held on May 13, 2020 at 4:30 p.m. and the Jury Trial will begin on June 1, 2020 at 9:30 a.m. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/5/2018.) Signed by Judge Colm F. Connolly on 11/28/2018. (nmf)
|
| Filing 41 NOTICE OF SERVICE of Adamas' Objections and Responses to Osmotica's First Set of Requests for the Production of Documents and Things (Nos. 1-116) filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
Filing 40
ORDER Setting Mediation Conference: A Telephone Conference is set for 1/28/2019 at 10:00 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 11/20/2018. (dlb)
|
| Filing 39 NOTICE OF SERVICE of Plaintiffs Responses & Objections to Defendants First Set of Requests for the Production of Documents and Things (Nos. 1-26) filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 38 NOTICE OF SERVICE of 1) Osmoticas Preliminary Invalidity Contentions and 2) Osmotica Pharmaceutical US LLC and Vertical Pharmaceuticals, LLCs document production BATES stamped OSMO_AMAN-0093689 through OSMO_AMAN-0094201 filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
SO ORDERED, re #37 STIPULATION TO EXTEND TIME by which Defendants shall file their opposition to the motion to dismiss, and by which plaintiffs to file a reply in support of the motion to dismiss to December 19, 2018 and January 9, 2019, respectively filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. Setting briefing schedule re #35 MOTION to Dismiss Based upon Fed. R. Civ. P. 12(b)(6) and 12(b)(1) Adamas' 35 U.S.C. 271(e)(2) Claims : (Answering Brief due 12/19/2018., Reply Brief due 1/9/2019.). Signed by Judge Colm F. Connolly on 11/16/2018. (fms)
|
| Filing 37 STIPULATION TO EXTEND TIME by which Defendants shall file their opposition to the motion to dismiss, and by which plaintiffs to file a reply in support of the motion to dismiss to December 19, 2018 and January 9, 2019, respectively - filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Pro Hac Vice Attorney Charles T. Wysocki for Osmotica Pharmaceutical US LLC,Vertical Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Filing 36 OPENING BRIEF in Support re #35 MOTION to Dismiss Based upon Fed. R. Civ. P. 12(b)(6) and 12(b)(1) Adamas' 35 U.S.C. 271(e)(2) Claims filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 11/19/2018. (Kraman, Pilar) |
| Filing 35 MOTION to Dismiss Based upon Fed. R. Civ. P. 12(b)(6) and 12(b)(1) Adamas' 35 U.S.C. 271(e)(2) Claims - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Attachments: #1 Text of Proposed Order)(Kraman, Pilar) |
| Filing 34 MOTION for Pro Hac Vice Appearance of Attorney Charles T. Wysocki - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Kraman, Pilar) |
SO ORDERED, re #34 MOTION for Pro Hac Vice Appearance of Attorney Charles T. Wysocki filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Signed by Judge Colm F. Connolly on 11/5/2018. (fms)
|
| Filing 33 NOTICE OF SERVICE of Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-116) to Defendants Adamas Pharmaceuticals, Inc. and Adamas Pharma LLC filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
Filing 32
ORDER Setting Mediation Conference: A Telephone Conference is set for 11/19/2018 at 10:45 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 10/23/2018. (dlb)
|
| CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Filing 31 NOTICE OF SERVICE of Adamas' First Set of Requests for the Production of Documents and Things filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 30 Joint STATUS REPORT by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Attachments: #1 Exhibit A)(Poff, Adam) |
SO ORDERED, re #29 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants' Counterclaims to November 5, 2018 filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Signed by Judge Colm F. Connolly on 10/4/2018. (fms)
|
| Filing 29 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants' Counterclaims to November 5, 2018 - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Kraman, Pilar) |
| Filing 28 NOTICE OF SERVICE of Adamas Pharmaceuticals Inc. and Adamas Pharma, LLC's Initial Infringement Contentions filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
ORAL ORDER: Pursuant to the reassignment of this action, the parties shall submit a joint status report on or before October 5, 2018. Please identify in the status report the next event the parties believe the Court needs to schedule. Ordered by Judge Colm F. Connolly on September 21, 2018. (nmf)
|
| CORRECTING ENTRY: The text of D.I. #27 has been corrected per request of filer to reflect that it is the "First Amended" Answer. (nmf) |
| Filing 27 FIRST AMENDED ANSWER to #1 Complaint, , COUNTERCLAIM against Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A)(Tigan, Jeremy) Modified on 9/21/2018 (nmf). |
| Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (jcs) |
| Filing 26 NOTICE of of Withdrawal of Notice of Intent to Redact Transcript by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC re #24 Notice of Intent to Request Transcript Redaction (Kraman, Pilar) |
| Filing 25 NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Plaintiffs Responses and Objections to Defendants First Set of Interrogatories filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 24 NOTICE of Intent to Request Redaction by Pilar Gabrielle Kraman re #22 Transcript,, (Kraman, Pilar) |
SO ORDERED - re #23 Letter and Scheduling Order: Case referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and to Amend Pleadings due by 2/28/2019., Claim Construction Opening Briefs due by 3/15/2019., Claim Construction Answering Briefs due by 5/10/2019., A Markman Hearing (3 hours) is set for 6/17/2019 at 9:30 AM in Courtroom 4B., Fact Discovery completed by 8/16/2019., Opening Expert Reports due by 9/12/2019., Rebuttal Expert Reports due by 10/31/2019., Reply Expert Reports due by 11/18/2019., Expert Discovery due by 1/10/2020., Opening Summary Judgment Letter briefs due by 1/17/2020., Answering Letter Briefs due 1/31/2020., Reply Brief due 2/7/2020., Proposed Final Pretrial Order due by 5/1/2020., A Final Pretrial Conference is set for 5/18/2020 at 10:00 AM in Courtroom 4B., and a 10-day Jury Trial is set for 6/15/2020 at 09:30 AM in Courtroom 4B). Ordered by Judge Gregory M. Sleet on 9/7/2018. (mdb)
|
| Filing 23 Letter to The Honorable Gregory M. Sleet from Adam W. Poff, Esquire regarding enclosing amended proposed scheduling order. (Attachments: #1 Joint Proposed Scheduling Order)(Poff, Adam) |
| Filing 22 Official Transcript of Teleconference held on 08/29/2018 before Judge Gregory Sleet. Court Reporter/Transcriber Dale C. Hawkins,Telephone number 302-573-6196. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/21/2018. Redacted Transcript Deadline set for 10/1/2018. Release of Transcript Restriction set for 11/29/2018. (dh) |
| Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 8/29/2018. Discussion regarding the opposing views on whether a jury trial or bench trial is appropriate. After more information was provided, the case will be scheduled for a jury trial, as follows: The parties' proposed schedule is adopted, with the following additions: A full day Markman Hearing is set for 6/17/2019 at 9:30 AM in Courtroom TBD, the Final Proposed Pretrial Order is due by the close of business on 5/1/2020, the Final Pretrial Conference is set for 5/18/2020 at 10:00 AM in Courtroom TBD, and a 10-day Jury Trial is set for 6/15/2020 at 9:30 AM in Courtroom TBD. The Daubert Motion deadlines shall be removed from the schedule. The plaintiffs shall file an amended proposed scheduling order by 9/5/2018. (Court Reporter Dale Hawkins.) (mdb) |
SO ORDERED - re #20 Proposed Stipulated Protective Order. Ordered by Judge Gregory M. Sleet on 8/29/2018. (mdb)
|
ORAL ORDER SCHEDULING A TELECONFERENCE: ORAL ORDER - A Telephone Conference re #16 Joint Status Report filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. is set for Wednesday, August 29, 2018, at 11:00 AM before Judge Gregory M. Sleet. Ordered by Judge Gregory M. Sleet on 8/22/2018. (asw)
|
| Filing 21 NOTICE OF SERVICE of Adamas' First Set of Interrogatories filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 20 Letter to The Honorable Gregory M. Sleet from Jeremy A. Tigan on behalf of the parties regarding agreed upon scheduling and protective orders. (Attachments: #1 Proposed Scheduling Order, #2 Proposed Protective Order)(Tigan, Jeremy) |
| Filing 19 NOTICE OF SERVICE of Osmotica Pharmaceutical US LLC and Vertical Pharmaceuticals, LLC s Core Technical Documents filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 18 NOTICE OF SERVICE of 1) Plaintiffs Rule 26(a)(1) Initial Disclosures and 2) Plaintiffs Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC.(Kraman, Pilar) |
| Filing 17 NOTICE OF SERVICE of (1) Adamas' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1); and (2) Adamas' Initial Disclosures Regarding Custodians and Non-Custodial Data Sources filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Filing 16 Joint STATUS REPORT by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| Filing 15 NOTICE requesting Clerk to remove Gaby L. Longsworth & Olga A. Partington as co-counsel.. (Kraman, Pilar) |
| Pro Hac Vice Attorney Adam LaRock for Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
SO ORDERED - re #14 MOTION for Pro Hac Vice Appearance of Attorney Adam LaRock filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Ordered by Judge Gregory M. Sleet on 7/2/2018. (mdb)
|
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Adam LaRock - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Poff, Adam) |
| Pro Hac Vice Attorney Isaac S. Ashkenazi, Scott F. Peachman, Bruce M. Wexler, and Alison Mulry for Adamas Pharma, LLC and Adamas Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
SO ORDERED - re #13 MOTION for Pro Hac Vice Appearance of Attorney Nirav N. Desai filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC, #12 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, J.C. Rozendaal, Gaby L. Longsworth, Daniel J. Ritterbeck, and Olga A. Partington filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Ordered by Judge Gregory M. Sleet on 5/10/2018. (mdb)
|
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Nirav N. Desai - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Kraman, Pilar) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, J.C. Rozendaal, Gaby L. Longsworth, Daniel J. Ritterbeck, and Olga A. Partington - filed by Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC. (Kraman, Pilar) |
SO ORDERED - re #11 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Scott F. Peachman and Alison Mulry of Paul Hastings (NYC) and Michael A. Stramiello of Paul Hastings LLP (DC) filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. Ordered by Judge Gregory M. Sleet on 4/26/2018. (mdb)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Scott F. Peachman and Alison Mulry of Paul Hastings (NYC) and Michael A. Stramiello of Paul Hastings LLP (DC) - filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Adamas Pharmaceuticals, Inc., for Adamas Pharma, LLC filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| Filing 9 ANSWER to #1 Complaint, by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc..(Blumenfeld, Jack) |
SO ORDERED - re #8 STIPULATION TO EXTEND TIME for Defendants Adamas Pharmaceuticals, Inc. and Adamas Pharma, LLC to Move, Answer, or Otherwise Respond to the Complaint to April 13, 2018 filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc., Set/Reset Answer Deadlines: Adamas Pharma, LLC answer due 4/13/2018; Adamas Pharmaceuticals, Inc. answer due 4/13/2018.. Ordered by Judge Gregory M. Sleet on 3/12/2018. (mdb)
|
| Filing 8 STIPULATION TO EXTEND TIME for Defendants Adamas Pharmaceuticals, Inc. and Adamas Pharma, LLC to Move, Answer, or Otherwise Respond to the Complaint to April 13, 2018 - filed by Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Filing 7 SUMMONS Returned Executed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Adamas Pharma, LLC served on 2/21/2018, answer due 3/14/2018. (Kraman, Pilar) |
| Filing 6 SUMMONS Returned Executed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Adamas Pharmaceuticals, Inc. served on 2/21/2018, answer due 3/14/2018. (Kraman, Pilar) |
| Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (nms) |
| Summons Issued with Magistrate Consent Notice attached as to Adamas Pharma, LLC on 2/20/2018; Adamas Pharmaceuticals, Inc. on 2/20/2018. (jcs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Vertical/Trigen Holdings, LLC for Vertical Pharmaceuticals, LLC filed by Vertical Pharmaceuticals, LLC. (fms) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Vertical/Trigen Holdings, LLC for Osmotica Pharmaceutical US LLC filed by Osmotica Pharmaceutical US LLC. (fms) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See report and addendum for patent numbers. (Attachments: #1 Addendum to Report)(fms) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Filing 1 COMPLAINT For Declaratory Judgment of Noninfringement filed with Jury Demand against Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2324945.) - filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. (Attachments: #1 Exhibits A - O, #2 Civil Cover Sheet)(fms) |
| No Summons Issued. (fms) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
SO ORDERED, re #86 STIPULATION TO EXTEND TIME to file Joint Claim Construction Brief to May 20, 2019 filed by Vertical Pharmaceuticals, LLC, Osmotica Pharmaceutical US LLC. Signed by Judge Colm F. Connolly on 5/17/2019. (nmf)